136 related articles for article (PubMed ID: 2573274)
1. Allele-specific deletion in exon I of the HRAS1 gene.
Kasperczyk A; Mermer BA; Parkinson DR; Lonergan JA; Krontiris TG
Am J Hum Genet; 1989 Nov; 45(5):689-96. PubMed ID: 2573274
[TBL] [Abstract][Full Text] [Related]
2. [Molecular nature of oncogene HRAS1 damage in human breast carcinoma: G----T transversion in codon 12 of one allele during deletion of other allele].
Kniazev PG; Serova OM; Babenko VI; Nikiforova IF; Gol'tseva AA; Pluzhnikova GF; Plutalov OV; Berlin IuA; Shvarts EI
Bioorg Khim; 1990 Mar; 16(3):419-23. PubMed ID: 2192714
[No Abstract] [Full Text] [Related]
3. Rare HRAS1 alleles outside the VTR region in lymph nodes from patients with malignant lymphoma.
Stul M; Baens M; Mecucci C; Van den Berghe H; Cassiman JJ
Cancer Genet Cytogenet; 1993 Aug; 69(1):60-4. PubMed ID: 8104094
[TBL] [Abstract][Full Text] [Related]
4. Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus.
Kasperczyk A; DiMartino NA; Krontiris TG
Am J Hum Genet; 1990 Nov; 47(5):854-9. PubMed ID: 2220825
[TBL] [Abstract][Full Text] [Related]
5. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons.
Takahashi H; Crystal RG
Am J Hum Genet; 1990 Sep; 47(3):403-13. PubMed ID: 1975477
[TBL] [Abstract][Full Text] [Related]
7. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
8. Dosage and allelic restriction fragment studies and PCR analysis of the H-ras locus in giant cell tumor of bone.
Dahir GA; Vnencak-Jones CL; Schwartz HS; Butler MG
Cancer Genet Cytogenet; 1994 Jun; 74(2):95-8. PubMed ID: 7912645
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Nat Genet; 1996 Mar; 12(3):309-11. PubMed ID: 8589723
[TBL] [Abstract][Full Text] [Related]
10. Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds.
Sutherland C; Shaw HM; Roberts C; Grace J; Stewart MM; McCarthy WH; Kefford RF
Br J Cancer; 1986 Nov; 54(5):787-90. PubMed ID: 2879551
[TBL] [Abstract][Full Text] [Related]
11. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.
Castresana JS; Rubio MP; Vázquez JJ; Idoate M; Sober AJ; Seizinger BR; Barnhill RL
Int J Cancer; 1993 Oct; 55(4):562-5. PubMed ID: 8104906
[TBL] [Abstract][Full Text] [Related]
12. An A gamma globin promoter (four base-pair deletion) mutant shows linked polymorphic changes throughout the A gamma gene.
Harvey MP; Motum P; Lindeman R; Trent RJ
Exp Hematol; 1992 Mar; 20(3):320-3. PubMed ID: 1373683
[TBL] [Abstract][Full Text] [Related]
13. Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1.
Yoshimoto K; Iizuka M; Iwahana H; Yamasaki R; Saito H; Saito S; Sekiya T
Cancer Res; 1989 May; 49(10):2716-21. PubMed ID: 2565762
[TBL] [Abstract][Full Text] [Related]
14. High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization.
Blonden LA; den Dunnen JT; van Paassen HM; Wapenaar MC; Grootscholten PM; Ginjaar HB; Bakker E; Pearson PL; van Ommen GJ
Nucleic Acids Res; 1989 Jul; 17(14):5611-21. PubMed ID: 2569720
[TBL] [Abstract][Full Text] [Related]
15. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
16. Detection of deletions, insertions and single nucleotide substitutions in cloned beta-globin genes and new polymorphic nucleotide substitutions in beta-globin genes in a Japanese population using ribonuclease cleavage at mismatches in RNA:DNA duplexes.
Hiyama K; Kodaira M; Satoh C
Mutat Res; 1990 Aug; 231(2):219-31. PubMed ID: 2385239
[TBL] [Abstract][Full Text] [Related]
17. A new RFLP in intron 1 of the human c-Ha-ras1 gene and its close relationship with the variable tandem repeats in the region 3' to the gene.
Iwahana H; Orita M; Kanazawa H; Hayashi K; Sekiya T
Oncogene; 1990 Jul; 5(7):1049-53. PubMed ID: 1973828
[TBL] [Abstract][Full Text] [Related]
18. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
Shan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
[TBL] [Abstract][Full Text] [Related]
19. Consistent allelic loss on mouse chromosome 7 distal to tyrosinase in 4-nitroquinoline-1-oxide-induced oral cavity tumors with loss of heterozygosity at Ha-ras-1.
Yuan B; Hu LH; Lentsch EM; Shum-Siu A; Hendler FJ
Mol Carcinog; 1997 May; 19(1):8-16. PubMed ID: 9180923
[TBL] [Abstract][Full Text] [Related]
20. Factor IXMadrid 2: a deletion/insertion in factor IX gene which abolishes the sequence of the donor junction at the exon IV-intron d splice site.
Solera J; Magallón M; Martin-Villar J; Coloma A
Am J Hum Genet; 1992 Feb; 50(2):434-7. PubMed ID: 1346483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
